Workflow
Lemonade: The AI Advantage That Could Tip The Scales
Seeking Alpha· 2025-06-12 10:47
"AWS Certified AI Practitioner Early Adopter"I am a DevOps Engineer for a major, wholly owned subsidiary of a large-cap Fortune 500. I am a true subject-matter expert on the actual buildout, deployment, and maintenance of AI tools and applications. I have increasingly deep knowledge on the science behind generative AI systems as a result of first-hand experience with machine learning algorithms, model training, and model deployment.I am currently in the process of obtaining more advanced AWS machine learnin ...
CNX Announces Promotion of Alan Shepard to President
Prnewswire· 2025-06-12 10:45
PITTSBURGH, June 12, 2025 /PRNewswire/ -- CNX Resources Corporation (NYSE: CNX) announces the promotion of Alan Shepard to the position of President in addition to his current role as Chief Financial Officer."The opportunity set for the CNX team to continue to create per-share value for our owners and to positively transform our Appalachian communities has never been greater," said Nick Deiuliis, CNX CEO. "Since rejoining CNX in 2020, Alan has been integral to the development, communication, and execution o ...
Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day
Prnewswire· 2025-06-12 10:45
Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.201 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283 Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth3,4 Raising long-term target for Other profit to ~10% normalized growth3,4,5 Updating GMPD long-term target to $50M+ of profit grow ...
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
Globenewswire· 2025-06-12 10:45
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy Acquisition of CureVac will complement BioNTech’s capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturing Public exchange offer for all shares of CureVac where each share of CureVac will be exchanged for approx. $5.46 in BioNTech American Deposit ...
ParaZero Technologies Strengthens U.S. Drone Leadership with Innovative Solutions in Live U.S. Demonstration
Globenewswire· 2025-06-12 10:45
Kfar Saba, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, announces its participation in recent live demonstrations and strategic engagements in the U.S. that underscore its commitment to advancing drone technologies used in the U.S., enhancing public safety, and supporting U.S. national security priorities. On June 4, 2025, ParaZe ...
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
Prnewswire· 2025-06-12 10:45
LAUSANNE, Switzerland, June 12, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into securities purchase agreements for the sale of its equity securities to certain institutional investors in a $100.0 million private investment in public equity ("PIPE") financing. In the PIPE, ADC Therapeutics is selling 13.0 million common shares at $3.53 per share and pre-funded warrants ...
Prudential: Still Attractive Valuation Despite Recent Share Price Run
Seeking Alpha· 2025-06-12 10:41
Despite Prudential (NYSE: PUK ) strong share price performance year-to-date, the company is still trading below its embedded value. This implies that the market is applying a negative value to its new business profits. This doesn't makeGrowth investor with a strong focus on the emerging markets.Disclaimer: Any content on this site is NOT investment, trading, legal, or tax advice, and none of the information available through this website is intended to provide tax, legal, investment, or trading advice. Noth ...
Buy Or Fear MP Materials Stock
Forbes· 2025-06-12 10:35
BEIJING, CHINA - MAY 17: Samples of rare-earth minerals from Baiyun'ebo or Bayan Obo mining district ... More are on display at the Institute of Geology and Geophysics, Chinese Academy of Sciences (IGGCAS) on May 17, 2025 in Beijing, China. (Photo by VCG/VCG via Getty Images)VCG via Getty ImagesMP Materials (NYSE:MP) stock appears very unappealing – making it a poor choice to purchase at its present price of approximately $27. We have identified several issues with MP stock, which contribute to its unattrac ...
Boeing Stock Faces Fresh Crisis After 787 Dreamliner Crash
Forbes· 2025-06-12 10:30
COPENHAGEN, DENMARK - 2024/05/22: An Air India Boeing 787-8 Dreamliner landing at Copenhagen Kastrup ... More airport. The Air India Boeing 787-8 aircraft seats 256 passengers in a two-class configuration and is used on long-haul routes. This aircraft have 18 seats in Business Class and 238 Economy. (Photo by Fabrizio Gandolfo/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesBoeing’s stock tumbled 6% in extended trading following news of a tragic crash involving one of its 78 ...
Metalpha Announces Successful Conclusion of Next Generation Fund with Exceptional Performance
Prnewswire· 2025-06-12 10:30
HONG KONG, June 12, 2025 /PRNewswire/ -- Metalpha Technology Holding Limited (Nasdaq: MATH) ("Metalpha" or the "Company"), a leading digital asset-focused wealth management company, today announced the successful completion of the LSQ Investment Fund SPC – Next Generation Fund I SP (the "Fund"), which delivered exceptional results over its two-year investment period.The Fund, managed by Metalpha's SFC Type 9 licensed subsidiary LSQ Capital Limited, commenced trading activities in late March 2023. From late ...